Greenleaf Peter 4
4 · Aurinia Pharmaceuticals Inc. · Filed Feb 22, 2024
Insider Transaction Report
Form 4
Greenleaf Peter
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-02-20+661,538→ 1,649,095 total
Footnotes (2)
- [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
- [F2]Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 2,386 shares of common stock were acquired on May 31, 2023 and 2,500 shares of common stock were acquired on November 30, 2023.